Interventional Radiology Market to Reach USD 21.3 Billion by 2035, Growing at 5.6% CAGR

According to the report, the interventional radiology market is anticipated to grow from USD 12.3 Billion in 2025 to USD 21.3 Billion in 2035 at a CAGR of 5.6% during the forecast period. The interventional radiology (IR) imaging market is continuing to expand as health systems move towards treatments that allow for the same or better outcomes with less invasive procedures requiring precision imaging. These imaging-guided procedures are routinely utilized in cardiology, oncology, and now emergency care due to less recovery time and other complications compared to traditional surgical approaches.

In 2024, hospitals expected to continue to utilize new AI-assisted IR systems that create real-time guidance along with some of the more complex interventions. Precision imaging systems expected to further enhance procedural accuracy, reduce the amount of radiation exposure to patient & staff, and improve patient safety. Hybrid operating rooms combined with portable IR systems make it easier than ever to integrate image-guided care in new places, such as outpatient clinics.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Interventional Radiology Market Research Report: https://marketgenics.co/press-releases/interventional-radiology-imaging-market-71336

Regional Analysis of Global Interventional Radiology Market

The interventional radiology market is led by North America due to the existing healthcare infrastructure, their adoption and usage of minimally invasive procedures, and funding for protected medical technologies. Europe has a major share as their healthcare systems are established, and there is a demand for more delicate and improved diagnostic and treatment approaches for patients.

Moreover, the Asia Pacific region is emerging rapidly due to more healthcare spending, an increasing awareness of the benefits of advanced imaging and improvements in hospital networks in countries like China and India. Other regions like Latin America, and the Middle East, have slowly adopted interventional imaging technologies benefitting from the increasing awareness developing healthcare facilities and government push.

Key players operating in the interventional radiology market include Agfa-Gevaert Group, Becton, Dickinson and Company (BD), Boston Scientific, Canon Medical Systems, Carestream Health, Esaote SpA, Fujifilm Healthcare, GE HealthCare, Hitachi Medical Systems, Hologic Inc., Medtronic, Neusoft Medical Systems, PerkinElmer, Philips Healthcare, Samsung Medison, Shimadzu Corporation, Siemens Healthineers, Ziehm Imaging, and other key players, along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.

To know more about the Interventional Radiology Market - Download our Sample Report: https://marketgenics.co/download-report-sample/interventional-radiology-imaging-market-71336

The Implications of Worldwide Tariff Regulations on the Interventional Radiology Market Industry Growth and Techniques

Trade policy impacts tariff regulations more indirectly but still meaningfully in the interventional radiology market. Because many of these imaging systems and components are imported (i.e., high-resolution detectors, AI-software modules, hardware parts), an increase in trade tariffs can reduce the availability of the equipment and drive up prices. Countries with limited medical imaging technology capabilities expected todepend more on imports, becoming more susceptible to any trade changes in the global market and more restrictive tariff regulations.

Therefore, major players are expecting from regional assembly hubs and technology licensing to reduce future dependencies on border crossings for logistics and thereafter costs of equipment. In order to maintain growth in response to external tariff pressures, companies are now investing in modular system designs, annual cloud updates, and service delivery models focused on digital, adding local value without adding cost.

Buy Now: https://marketgenics.co/buy/interventional-radiology-imaging-market-71336

Recent Development and Strategic Overview:

In March 2025, Philips Healthcare has introduced the Azurion SpectraFlex, an innovative image-guided therapy platform for the next-generation of procedures for complex interventional cardiology and oncology patients. The launch also featured SmartResponse+, an artificial intelligence powered clinical support system that uses a variety of procedural data points, real-time patient vitals, and pre-operative imaging to assist physicians to navigate procedural decisions faster and more safely.

In February 2025, Canon Medical Systems announced Alphenix 4D Fusion, a dynamic interventional imaging platform that offers ultra-clear, real-time 4D vascular imaging for neuro and peripheral interventions. In addition to the hardware, Canon introduced IRiView AI, a clinical decision support platform that incorporates patient history, procedural imaging, and the history of contrast usage by the physician along with regulatory and safety associated with the active imaging device to alert physicians to any potential risks during the intervention.

Get a preview of our Interventional Radiology Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/interventional-radiology-imaging-market-71336

Key Trend: AI-Powered Imaging, Shift toward Outpatient Care, and Hybrid Operating Rooms

Interventional radiology is experiencing several key trends, with the increasing integration of artificial intelligence (AI) and machine learning being the most obvious trend. AI has generated excitement in the field because it has potential to improve clinical performance and real-time image interpretation, helping radiologists detect abnormalities more quickly, improve procedural accuracy, and help reduce the fatigue related errors.

Another large shift is the migration to outpatient care; using our IR imaging of minimally invasive procedures, it is now a common practice to perform IR guided procedures without a hospitalization, helping alleviate some burden from the healthcare system and bring more convenience to patients.

Furthermore, hybrid operating rooms are being developed these spaces combine surgical equipment with advanced imaging systems and have been increasingly utilized in hospitals. Hybrid operating rooms enable the more efficient execution of open and minimally invasive surgery in one place, while also enhancing the safety of the patient. These trends are transforming the how, where, and when IR imaging takes place in the clinical setting.

ontact:

Mr. Debashish Roy

MarketGenics India Pvt. Ltd.

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

About Us

MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.

We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.

This release was published on openPR.